All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0487 | Anti-EYA2 (CBFYE-0271) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0271 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0488 | Anti-EYA2 (CBFYE-0272) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0272 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0489 | Anti-EYA2 (CBFYE-1423) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1423 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0490 | Anti-EYA2 (CBFYE-1424) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1424 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0491 | Anti-EYA2 (CBFYE-1425) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1425 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3740 | Anti-EYA2 (CBFYE-0271) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0271 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3741 | Anti-EYA2 (CBFYE-0272) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0272 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3742 | Anti-EYA2 (CBFYE-1423) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1423 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3743 | Anti-EYA2 (CBFYE-1424) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1424 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3744 | Anti-EYA2 (CBFYE-1425) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1425 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION